Burness ML - Search Results

1

Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?

Burness ML, Olopade OI. Burness ML, et al. J Clin Oncol. 2011 May 1;29(13):1652-4. doi: 10.1200/JCO.2010.32.5274. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444875 No abstract available.

2

Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report.

Burness ML, Obeid EI, Olopade OI. Burness ML, et al. Clin Breast Cancer. 2015 Apr;15(2):e155-8. doi: 10.1016/j.clbc.2014.08.006. Epub 2014 Sep 28. Clin Breast Cancer. 2015. PMID: 25445425 No abstract available.

3

Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?

Burness ML, Grushko TA, Olopade OI. Burness ML, et al. Cancer J. 2010 Jan-Feb;16(1):23-32. doi: 10.1097/PPO.0b013e3181d24fc1. Cancer J. 2010. PMID: 20164687 Review.

4

Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.

Jennaro TS, Fang F, Kidwell KM, Smith EML, Vangipuram K, Burness ML, Griggs JJ, Van Poznak C, Hayes DF, Henry NL, Hertz DL. Jennaro TS, et al. Among authors: burness ml. Breast Cancer Res Treat. 2020 Apr;180(3):707-714. doi: 10.1007/s10549-020-05584-8. Epub 2020 Mar 12. Breast Cancer Res Treat. 2020. PMID: 32166478 Free PMC article.

5

The stem cell niche in health and malignancy.

Burness ML, Sipkins DA. Burness ML, et al. Semin Cancer Biol. 2010 Apr;20(2):107-15. doi: 10.1016/j.semcancer.2010.05.006. Epub 2010 May 25. Semin Cancer Biol. 2010. PMID: 20510363 Review.

6

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.

Hertz DL, Kidwell KM, Vangipuram K, Li F, Pai MP, Burness M, Griggs JJ, Schott AF, Van Poznak C, Hayes DF, Lavoie Smith EM, Henry NL. Hertz DL, et al. Clin Cancer Res. 2018 Aug 1;24(15):3602-3610. doi: 10.1158/1078-0432.CCR-18-0656. Epub 2018 Apr 27. Clin Cancer Res. 2018. PMID: 29703818 Free PMC article.

7

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer.

Brooks MD, Burness ML, Wicha MS. Brooks MD, et al. Among authors: burness ml. Cell Stem Cell. 2015 Sep 3;17(3):260-71. doi: 10.1016/j.stem.2015.08.014. Cell Stem Cell. 2015. PMID: 26340526 Free PMC article. Review.

8

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.

Liu Y, Burness ML, Martin-Trevino R, Guy J, Bai S, Harouaka R, Brooks MD, Shang L, Fox A, Luther TK, Davis A, Baker TL, Colacino J, Clouthier SG, Shao ZM, Wicha MS, Liu S. Liu Y, et al. Among authors: burness ml. Clin Cancer Res. 2017 Jan 15;23(2):514-522. doi: 10.1158/1078-0432.CCR-15-1348. Epub 2016 Dec 29. Clin Cancer Res. 2017. PMID: 28034904

9

Factors influencing scalp cooling discussions and use at a large academic institution: a single-center retrospective review.

Novice T, Novice M, Portney D, Goyert J, Henry NL, Jeruss JS, Burness ML. Novice T, et al. Among authors: burness ml. Support Care Cancer. 2022 Oct;30(10):8349-8355. doi: 10.1007/s00520-022-07285-y. Epub 2022 Jul 23. Support Care Cancer. 2022. PMID: 35870021

10

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.

Price TT, Burness ML, Sivan A, Warner MJ, Cheng R, Lee CH, Olivere L, Comatas K, Magnani J, Kim Lyerly H, Cheng Q, McCall CM, Sipkins DA. Price TT, et al. Among authors: burness ml. Sci Transl Med. 2016 May 25;8(340):340ra73. doi: 10.1126/scitranslmed.aad4059. Sci Transl Med. 2016. PMID: 27225183 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters